Trial · NCT02720094
Results by group392
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 392
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Documented Incident HIV Infections During Steps 1 and 2 | Cabotegravir | 13 | Participants | ||
| Number of Participants With Documented Incident HIV Infections During Steps 1 and 2 | TDF/FTC | 39 | Participants | ||
| Number of Participants Experiencing Grade 2 or Higher Clinical and Laboratory Adverse Events | Cabotegravir | 2106 | Participants | ||
| Number of Participants Experiencing Grade 2 or Higher Clinical and Laboratory Adverse Events | TDF/FTC | 2116 | Participants | ||
| Number of Participants With Documented Incident HIV Infections in Step 2 | Cabotegravir | 8 | Participants | ||
| Number of Participants With Documented Incident HIV Infections in Step 2 | TDF/FTC | 37 | Participants | ||
| Changes From Baseline in Creatinine and Creatinine Clearance Levels | Cabotegravir | Week 57 (Injection #8) | 0.90 | Inter-Quartile Range -5.30 to 7.10 | umol/L |
| Changes From Baseline in Creatinine and Creatinine Clearance Levels | TDF/FTC | Week 57 (Injection #8) | 1.70 | Inter-Quartile Range -4.40 to 7.90 | umol/L |
| Changes From Baseline in Creatinine and Creatinine Clearance Levels | Cabotegravir | Week 105 (Injection #14) | 0.90 | Inter-Quartile Range -5.30 to 8.80 | umol/L |
| Changes From Baseline in Creatinine and Creatinine Clearance Levels | TDF/FTC | Week 105 (Injection #14) | 2.30 | Inter-Quartile Range -3.50 to 8.80 | umol/L |
| Number of Participants With Grade 3 or 4 Liver-related Adverse Events (AEs) | Cabotegravir | 73 | Participants | ||
| Number of Participants With Grade 3 or 4 Liver-related Adverse Events (AEs) | TDF/FTC | 96 | Participants | ||
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | Cabotegravir | Any resistance | 8 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | TDF/FTC | Any resistance | 13 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | Cabotegravir | PI resistance | 0 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | TDF/FTC | PI resistance | 0 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | Cabotegravir | NNRTI resistance | 3 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | TDF/FTC | NNRTI resistance | 10 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | Cabotegravir | NRTI resistance | 1 | Participants | |
| Incidence of Resistance Mutations to Study Products (Including But Not Limited to K65R, M184V/I, Q148R) Among Seroconverters | TDF/FTC | NRTI resistance | 6 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02720094/results